Source: Eur Respir J 2010; 35: 1322-1328
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kim E. J., Elicker B. M., Maldonado F., Webb W. R., Ryu J. H., Van Uden J. H., Lee J. S., King T. E. Jr, Collard H. R.. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35: 1322-1328

Member's Comments

No comment yet.

Related content which might interest you: Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome Source: Eur Respir J 2011; 37: 1411-1417 Year: 2011 Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Mortality and clinical features in rheumatoid arthritis and interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease Source: Eur Respir J 2016; 47: 588-596 Year: 2016 Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Radiologic pattern as a survival predictor in the rheumatoid artritis intersticial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Methotrexate and rheumatoid arthritis associated interstitial lung disease Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020 Year: 2021 Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Rituximab improves interstitial lung disease in rheumatoid arthritis patients Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 A prognostic staging system for rheumatoid arthritis-associated interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Predicting outcomes in rheumatoid arthritis related interstitial lung disease Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018 Year: 2019 Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA) Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease Source: International Congress 2016 – ILD pathogenesis Year: 2016 Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy Source: International Congress 2014 – ILDs 4 Year: 2014 Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new Source: Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020 Year: 2020 Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Differences in chest HRCT between smoking and non-smoking rheumatoid arthritis patients with abnormal spirometry Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013